Nanostics Receives Funding from the University of Alberta Innovation Fund
EDMONTON, AB, April 23, 2024 /CNW/ – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today that it received an investment from the University of Alberta Innovation Fund (UAIF) to help propel adoption of Nanostics’ ClarityDX Prostate® test in North America. Nanostics logo www.nanosticsdx.com (CNW Group/Nanostics) One in eight men will be diagnosed with prostate cancer in […]